BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 35915054)

  • 1. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles: A bright star of nanomedicine.
    Wu P; Zhang B; Ocansey DKW; Xu W; Qian H
    Biomaterials; 2021 Feb; 269():120467. PubMed ID: 33189359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles.
    Cheng X; Henick BS; Cheng K
    ACS Nano; 2024 Mar; 18(9):6748-6765. PubMed ID: 38393984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
    Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
    Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of engineered extracellular vesicles for targeted tumor therapy.
    Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
    J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine.
    Fan Z; Jiang C; Wang Y; Wang K; Marsh J; Zhang D; Chen X; Nie L
    Nanoscale Horiz; 2022 Jun; 7(7):682-714. PubMed ID: 35662310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer.
    Kugeratski FG; McAndrews KM; Kalluri R
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33411885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine.
    Rosso G; Cauda V
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications.
    Ziegler JN; Tian C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Extracellular Vesicles for Cancer Therapy.
    Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
    Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
    Ahmadi M; Hassanpour M; Rezaie J
    Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.